Results 51 to 60 of about 113,618,068 (200)

Cancer antigen 15-3/mucin 1 Levels in CCTG MA.32:a breast cancer randomized trial of metformin vs placebo [PDF]

, 2021
Background: Circulating levels of cancer antigen (CA) 15-3, a tumor marker and regulator of cellular metabolism, were reduced by metformin in a nonrandomized neoadjuvant study.
Gelmon, Karen A, Rabaglio-Poretti, Manuela, Chen, Bingshu E, Rea, Daniel W, Dowling, Ryan J O, Parulekar, Wendy R, Lemieux, Julie, Ennis, Marguerite, Goodwin, Pamela J, Thompson, Alastair M, Whelan, Timothy J, Hershman, Dawn L, Stambolic, Vuk, Hobday, Timothy J, Shepherd, Lois E, Ligibel, Jennifer A, Mayer, Ingrid A, Rastogi, Priya, Jennifer A Ligibel, Bingshu E Chen, Karen A Gelmon, Manuela Rabaglio-Poretti, Timothy J Whelan, Wendy R Parulekar, Marguerite Ennis, Pamela J Goodwin, Vuk Stambolic, Daniel W Rea, Timothy J Hobday, Priya Rastogi, Julie Lemieux, Dawn L Hershman, Ingrid A Mayer, Alastair M Thompson, Ryan J O Dowling, Lois E Shepherd   +35 more
core   +1 more source

Utility of CA15-3 as a Tumour Proliferation Marker in Breast Carcinoma Patients: A Cross-sectional Study Protocol

Journal of Clinical and Diagnostic Research
Introduction: The Carcinoma Antigen (CA) 15-3 is a protein antigen from the mucin family that contains carbohydrates. It has shown potential as a tumour marker in breast cancer for detection, diagnosis, prognosis, therapy monitoring and assessing disease
Apoorva Pande, Samarth Shukla, Milind Pande, Suhit Naseri, Saurabh Gawand   +4 more
doaj   +1 more source

Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review

BMC Medicine, 2012
Background Recent insights provide support for the treatment of cancer during pregnancy, a coincidence that poses both mother and fetus at risk. Our aim was to critically review studies on the physiologic variations during pregnancy, the most common ...
Han Sileny N, Lotgerink Anouk, Gziri Mina, Van Calsteren Kristel, Hanssens Myriam, Amant Frédéric   +5 more
doaj   +1 more source

Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.

, 2013
To investigate the prognostic value of tumor markers, cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) levels at diagnosis of systemic recurrence.
이준상, 김승일, 박지민, 조정훈, 박병우, 박세호   +5 more
core   +1 more source

CA 15–3 Serum Levels in Patients with Ductal Breast Carcinoma: Relationship with Clinicopathological Parameters and Tumor Markers

The International Journal of Biological Markers, 2012
Introduction Cancer antigen 15–3 (CA 15–3) is the most widely used serum marker in diagnosing and monitoring breast cancer. The aim of this work was to analyze preoperative CA 15–3 serum levels in patients with ductal breast carcinoma in relation to 1 ...
Angel González-Sistal MD, PhD, José Ignacio Arias, Álvaro Ruibal   +2 more
doaj   +1 more source

sj-docx-1-jbm-10.1177_03936155231158661 - Supplemental material for Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers

, 2023
Supplemental material, sj-docx-1-jbm-10.1177_03936155231158661 for Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers by Farzaneh Fazli Khalaf, Mehrnaz Asadi Gharabaghi ...
Farzaneh Fazli Khalaf (14821455), Hamidreza Davari (14821461), Maryam Balibegloo (13113532), Mehrnaz Asadi Gharabaghi (14821458), Samaneh Afshar (14821464), Behnaz Jahanbin (14821467)   +5 more
core   +1 more source

Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer

The International Journal of Biological Markers, 1989
In order to assess the utility of the tumor-associated antigen CA15-3 in the diagnosis of breast cancer, this new tumor marker was measured pre-operatively in 1342 patients. This group comprised 509 patients with malignant disease (134 with breast cancer
F. Safi, I. Kohler, E. Röttinger, P. Suhr, H. G. Beger   +4 more
doaj   +1 more source

MUC-1 (CA 15–3 Antigen) as a Highly Reliable Predictor of Response to EGFR Inhibitors in Patients with Bronchioloalveolar Carcinoma: An Experience on 26 Patients

The International Journal of Biological Markers, 2007
Background Bronchioloalveolar carcinoma (BAC) is a histological subtype of non-small cell lung cancer (NSCLC), particularly of adenocarcinoma. Given its multifocality and the poor activity of chemotherapy, there is no established treatment for BAC ...
A. Bearz MD, R. Talamini, E. Vaccher, M. Spina, C. Simonelli, A. Steffan, M. Berretta, E. Chimienti, U. Tirelli   +8 more
doaj   +1 more source

Axillary lymph node metastasis: CA-15-3 and carcinoembryonic antigen concentrations in fine-needle aspirates for preoperative diagnosis in patients with breast cancer

, 2010
Purpose: To assess whether concentrations of the tumor markers breast cancer antigen 15-3 (CA-15-3) and carcinoembryonic antigen (CEA) in fine-needle aspirates (FNAs) differ between benign and malignant lymph nodes and whether FNA concentrations of the ...
임종백, 손유미, 곽진영, 문희정, 박성희, 김수진, 김은경, 김민정, 박병우, 김현숙, Byeong-Woo Park, Hee Jung Moon, Yu-Mee Sohn, Sung Hee Park, Jong-Baeck Lim, Eun-Kyung Kim, Jin Young Kwak, Soo Jin Kim, Hyon-Suk Kim, Min Jung Kim   +19 more
core   +1 more source

FOLLOW-UP OF PATIENTS AND PROGNOSTIC IMPACT OF TUMOUR MARKER CA 15-3 ON PATIENTS OF BREAST CANCER: A RETROSPECTIVE COHORT STUDY

, 2020
Introduction:Breast cancer is the most common cancer in women, with 5- and 10-year relative survival rates are 91% and 84%, respectively for women with invasive breast cancer.
Anjali Vinocha
core   +1 more source